Abstract A 63-year-old male with a recently diagnosed right lung lesion was referred for staging. F-FDG PET/CT scan revealed a hypodense, cystic-like mass in the right upper lung lobe, which demonstrated low, diffuse 18 F-FDG uptake, likely due to the presence of mucus, as well as intensely hypermetabolic right hilar and right paratracheal lymph nodes. Transbronchial biopsy revealed a primary pulmonary mucinous cystadenocarcinoma with the presence of signet ring cell carcinoma, a co-existence of two rare variants of lung adenocarcinoma. This case report demonstrates the metabolic phenotype along with the radiographic characteristics of this rare tumor and its metastases.
F-FDG uptake (SUVmax: 2.8) (white arrows). Multiple intensely hypermetabolic right hilar and right paratracheal lymph nodes were also noted, finding suspicious for metastatic disease (SUVmax: up to 9.3) (white arrowheads). Anatomic and metabolic appearances of the primary lung lesion were consistent with presence of mucus, pointing towards a possible diagnosis of mucinous cystadenocarcinoma, a rare variant of lung adenocarcinoma [1, 2] . Raza et al. have reported another case of mucinous cystadenocarcinoma, which also showed heterogeneous uptake in F-FDG PET f images (middle row, white arrows) show a 18 mm part-solid nodule in the left upper lobe with ground-glass component, which demonstrates faint FDG uptake (SUVmax 1.6). Taking into consideration that these tumors rarely metastasize to the contralateral hemithorax [6] , this finding could be inflammatory in nature, however malignant involvement could not be entirely excluded. There is also a moderate right pleural effusion seen on axial non-contrast CT g, fused Fig. 1: D) , suspicious for malignant pleural effusion. Fine needle aspiration of the effusion was positive for malignancy, which concurs with other case reports in the literature [7] . The disease was considered metastatic and only the right upper lung mass was biopsied
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